Is tall cell variant papillary thyroid cancer automatically categorized as intermediate risk regardless of other histopathological features and should consequently be treated with RAI?
Community PollStarted
Would you give RAI in tall cell variant PTC under 2 cm with clear margins and negative nodes?
34 physicians have voted
Join Mednetto vote and see how they answered.
1 Answer
Mednet MemberInvited Expert
Endocrinology · BMCWorking Well Occupational Health Clinic
Answered on
Tall cell PTC always has a BRAFV600E mutation and should automatically make the patient an ATA intermediate Initial Risk. But not all intermediate risk patients should get RAI RX. With small tumors, no ETE, no nodes AND if the 6 week postop Tg is < 1, I would do "delayed therapy" with "watchful wait...
Join for free or sign in to see the full answer